The Marijuana Herald – Marijuana news and information
The University of California (UC) is seeking participants for a double-blind, randomized clinical trial “examining the preliminary efficacy of psilocybin therapy for people with chronic low back pain”.
(Photo credit: TheScientist).
“This study evaluates whether psilocybin therapy helps patients cope with chronic low back pain more effectively”, states a public posting .” Patients may be recruited at Stanford and University of California San Francisco (UCSF), study procedures will occur at UCSF.”
Each participant “will receive a dose of psilocybin with possibly one or more other drugs. Participants will undergo two preparation sessions, a dosing session, three integration sessions to discuss their psilocybin experience, and several follow up sessions.” The began in December 2023, but recently opened up for new applicants. The study is expected to be completed by December of this year…